CA3237383A1 - Implants capillaires comprenant des caracteristiques d'ancrage et de securite medicale ameliorees - Google Patents
Implants capillaires comprenant des caracteristiques d'ancrage et de securite medicale ameliorees Download PDFInfo
- Publication number
- CA3237383A1 CA3237383A1 CA3237383A CA3237383A CA3237383A1 CA 3237383 A1 CA3237383 A1 CA 3237383A1 CA 3237383 A CA3237383 A CA 3237383A CA 3237383 A CA3237383 A CA 3237383A CA 3237383 A1 CA3237383 A1 CA 3237383A1
- Authority
- CA
- Canada
- Prior art keywords
- hair
- implant
- anchor
- anchor body
- collagen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 210000004209 hair Anatomy 0.000 title claims abstract description 1189
- 239000007943 implant Substances 0.000 title claims abstract description 690
- 238000004873 anchoring Methods 0.000 title abstract description 49
- 102000008186 Collagen Human genes 0.000 claims abstract description 146
- 108010035532 Collagen Proteins 0.000 claims abstract description 146
- 229920001436 collagen Polymers 0.000 claims abstract description 146
- 238000002513 implantation Methods 0.000 claims abstract description 72
- 230000012010 growth Effects 0.000 claims abstract description 28
- 230000008878 coupling Effects 0.000 claims abstract description 5
- 238000010168 coupling process Methods 0.000 claims abstract description 5
- 238000005859 coupling reaction Methods 0.000 claims abstract description 5
- 238000000034 method Methods 0.000 claims description 64
- 238000007920 subcutaneous administration Methods 0.000 claims description 41
- 238000007373 indentation Methods 0.000 claims description 10
- 238000010276 construction Methods 0.000 abstract description 8
- 210000003491 skin Anatomy 0.000 description 110
- 239000000463 material Substances 0.000 description 59
- 210000004761 scalp Anatomy 0.000 description 57
- 238000013461 design Methods 0.000 description 46
- 210000000987 immune system Anatomy 0.000 description 42
- 229920001296 polysiloxane Polymers 0.000 description 41
- 208000005422 Foreign-Body reaction Diseases 0.000 description 40
- 230000000717 retained effect Effects 0.000 description 40
- 201000004384 Alopecia Diseases 0.000 description 39
- 210000003780 hair follicle Anatomy 0.000 description 32
- 238000005755 formation reaction Methods 0.000 description 29
- 230000015572 biosynthetic process Effects 0.000 description 28
- 230000003676 hair loss Effects 0.000 description 28
- 208000024963 hair loss Diseases 0.000 description 28
- 230000003325 follicular Effects 0.000 description 27
- 238000006243 chemical reaction Methods 0.000 description 24
- 208000015181 infectious disease Diseases 0.000 description 23
- 238000001356 surgical procedure Methods 0.000 description 23
- 239000012634 fragment Substances 0.000 description 22
- 230000004054 inflammatory process Effects 0.000 description 21
- 230000003803 hair density Effects 0.000 description 20
- 210000002615 epidermis Anatomy 0.000 description 19
- 239000000835 fiber Substances 0.000 description 19
- 206010061218 Inflammation Diseases 0.000 description 18
- 210000004027 cell Anatomy 0.000 description 18
- 230000000694 effects Effects 0.000 description 18
- 239000003292 glue Substances 0.000 description 17
- 230000001580 bacterial effect Effects 0.000 description 16
- 238000011282 treatment Methods 0.000 description 16
- 241000894006 Bacteria Species 0.000 description 14
- 239000007788 liquid Substances 0.000 description 14
- 230000007246 mechanism Effects 0.000 description 14
- 239000000126 substance Substances 0.000 description 14
- 230000004888 barrier function Effects 0.000 description 13
- 239000007787 solid Substances 0.000 description 13
- 210000003484 anatomy Anatomy 0.000 description 12
- 238000004519 manufacturing process Methods 0.000 description 12
- 239000000853 adhesive Substances 0.000 description 11
- 230000001070 adhesive effect Effects 0.000 description 11
- -1 polypropylene Polymers 0.000 description 11
- 229920002379 silicone rubber Polymers 0.000 description 11
- 239000000243 solution Substances 0.000 description 11
- 239000011800 void material Substances 0.000 description 11
- 241000700201 Galea Species 0.000 description 10
- 210000004709 eyebrow Anatomy 0.000 description 10
- 210000001519 tissue Anatomy 0.000 description 10
- 230000008901 benefit Effects 0.000 description 9
- 230000008569 process Effects 0.000 description 9
- 230000037390 scarring Effects 0.000 description 9
- 239000004945 silicone rubber Substances 0.000 description 9
- 239000011176 biofiber Substances 0.000 description 8
- 208000037976 chronic inflammation Diseases 0.000 description 8
- 230000006020 chronic inflammation Effects 0.000 description 8
- 239000011248 coating agent Substances 0.000 description 8
- 238000000576 coating method Methods 0.000 description 8
- 238000002316 cosmetic surgery Methods 0.000 description 8
- 230000007774 longterm Effects 0.000 description 8
- 229910052751 metal Inorganic materials 0.000 description 8
- 239000002184 metal Substances 0.000 description 8
- 238000007254 oxidation reaction Methods 0.000 description 8
- 239000004447 silicone coating Substances 0.000 description 8
- ZFMITUMMTDLWHR-UHFFFAOYSA-N Minoxidil Chemical compound NC1=[N+]([O-])C(N)=CC(N2CCCCC2)=N1 ZFMITUMMTDLWHR-UHFFFAOYSA-N 0.000 description 7
- 208000002193 Pain Diseases 0.000 description 7
- 240000007643 Phytolacca americana Species 0.000 description 7
- 235000009074 Phytolacca americana Nutrition 0.000 description 7
- 230000001154 acute effect Effects 0.000 description 7
- 239000012620 biological material Substances 0.000 description 7
- 210000000481 breast Anatomy 0.000 description 7
- 238000000605 extraction Methods 0.000 description 7
- 230000001815 facial effect Effects 0.000 description 7
- 229960004039 finasteride Drugs 0.000 description 7
- DBEPLOCGEIEOCV-WSBQPABSSA-N finasteride Chemical compound N([C@@H]1CC2)C(=O)C=C[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H](C(=O)NC(C)(C)C)[C@@]2(C)CC1 DBEPLOCGEIEOCV-WSBQPABSSA-N 0.000 description 7
- 230000006870 function Effects 0.000 description 7
- 210000003128 head Anatomy 0.000 description 7
- 229960003632 minoxidil Drugs 0.000 description 7
- 239000011148 porous material Substances 0.000 description 7
- 238000012552 review Methods 0.000 description 7
- 238000002054 transplantation Methods 0.000 description 7
- 230000000890 antigenic effect Effects 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 230000009977 dual effect Effects 0.000 description 6
- 230000035876 healing Effects 0.000 description 6
- 208000014674 injury Diseases 0.000 description 6
- 230000003647 oxidation Effects 0.000 description 6
- 230000036407 pain Effects 0.000 description 6
- 229920003023 plastic Polymers 0.000 description 6
- 239000004033 plastic Substances 0.000 description 6
- 229920000642 polymer Polymers 0.000 description 6
- 230000008733 trauma Effects 0.000 description 6
- 239000004952 Polyamide Substances 0.000 description 5
- 230000003444 anaesthetic effect Effects 0.000 description 5
- 230000001684 chronic effect Effects 0.000 description 5
- 229940079593 drug Drugs 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- 230000002500 effect on skin Effects 0.000 description 5
- 230000002349 favourable effect Effects 0.000 description 5
- 238000013467 fragmentation Methods 0.000 description 5
- 238000006062 fragmentation reaction Methods 0.000 description 5
- 230000033687 granuloma formation Effects 0.000 description 5
- 230000003779 hair growth Effects 0.000 description 5
- 238000001746 injection moulding Methods 0.000 description 5
- 238000012966 insertion method Methods 0.000 description 5
- 230000003993 interaction Effects 0.000 description 5
- 230000014759 maintenance of location Effects 0.000 description 5
- 229920002647 polyamide Polymers 0.000 description 5
- 230000002265 prevention Effects 0.000 description 5
- 230000009897 systematic effect Effects 0.000 description 5
- 210000001578 tight junction Anatomy 0.000 description 5
- 230000007704 transition Effects 0.000 description 5
- 206010002091 Anaesthesia Diseases 0.000 description 4
- 239000004698 Polyethylene Substances 0.000 description 4
- 230000037005 anaesthesia Effects 0.000 description 4
- 230000003796 beauty Effects 0.000 description 4
- 229920000249 biocompatible polymer Polymers 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 238000004891 communication Methods 0.000 description 4
- 230000006854 communication Effects 0.000 description 4
- 239000002537 cosmetic Substances 0.000 description 4
- 230000007423 decrease Effects 0.000 description 4
- 238000010586 diagram Methods 0.000 description 4
- 238000005538 encapsulation Methods 0.000 description 4
- 230000002757 inflammatory effect Effects 0.000 description 4
- 230000028709 inflammatory response Effects 0.000 description 4
- 229920002529 medical grade silicone Polymers 0.000 description 4
- 229920000728 polyester Polymers 0.000 description 4
- 229920000573 polyethylene Polymers 0.000 description 4
- 229920000915 polyvinyl chloride Polymers 0.000 description 4
- 239000004800 polyvinyl chloride Substances 0.000 description 4
- 230000002829 reductive effect Effects 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- 230000004044 response Effects 0.000 description 4
- 230000035882 stress Effects 0.000 description 4
- 208000035143 Bacterial infection Diseases 0.000 description 3
- 208000032544 Cicatrix Diseases 0.000 description 3
- 229920001651 Cyanoacrylate Polymers 0.000 description 3
- 201000004624 Dermatitis Diseases 0.000 description 3
- 206010016936 Folliculitis Diseases 0.000 description 3
- 206010052899 Ingrown hair Diseases 0.000 description 3
- NNJVILVZKWQKPM-UHFFFAOYSA-N Lidocaine Chemical compound CCN(CC)CC(=O)NC1=C(C)C=CC=C1C NNJVILVZKWQKPM-UHFFFAOYSA-N 0.000 description 3
- MWCLLHOVUTZFKS-UHFFFAOYSA-N Methyl cyanoacrylate Chemical group COC(=O)C(=C)C#N MWCLLHOVUTZFKS-UHFFFAOYSA-N 0.000 description 3
- 206010062575 Muscle contracture Diseases 0.000 description 3
- 208000000528 Pilonidal Sinus Diseases 0.000 description 3
- 206010035043 Pilonidal cyst Diseases 0.000 description 3
- 239000004743 Polypropylene Substances 0.000 description 3
- 229920001328 Polyvinylidene chloride Polymers 0.000 description 3
- 206010000496 acne Diseases 0.000 description 3
- 230000002411 adverse Effects 0.000 description 3
- 231100000360 alopecia Toxicity 0.000 description 3
- 206010068168 androgenetic alopecia Diseases 0.000 description 3
- 201000002996 androgenic alopecia Diseases 0.000 description 3
- 239000003242 anti bacterial agent Substances 0.000 description 3
- 229940088710 antibiotic agent Drugs 0.000 description 3
- 208000022362 bacterial infectious disease Diseases 0.000 description 3
- 238000005842 biochemical reaction Methods 0.000 description 3
- 230000001413 cellular effect Effects 0.000 description 3
- 230000008602 contraction Effects 0.000 description 3
- 208000006111 contracture Diseases 0.000 description 3
- 210000004292 cytoskeleton Anatomy 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 238000009826 distribution Methods 0.000 description 3
- 230000002996 emotional effect Effects 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 230000003628 erosive effect Effects 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 210000003195 fascia Anatomy 0.000 description 3
- 230000002068 genetic effect Effects 0.000 description 3
- 230000000762 glandular Effects 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 229960004194 lidocaine Drugs 0.000 description 3
- 229910001092 metal group alloy Inorganic materials 0.000 description 3
- 230000002906 microbiologic effect Effects 0.000 description 3
- 244000005700 microbiome Species 0.000 description 3
- 230000005012 migration Effects 0.000 description 3
- 238000013508 migration Methods 0.000 description 3
- 206010033675 panniculitis Diseases 0.000 description 3
- 230000036961 partial effect Effects 0.000 description 3
- 229920001155 polypropylene Polymers 0.000 description 3
- 229920002635 polyurethane Polymers 0.000 description 3
- 239000004814 polyurethane Substances 0.000 description 3
- 239000005033 polyvinylidene chloride Substances 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 231100000241 scar Toxicity 0.000 description 3
- 230000037387 scars Effects 0.000 description 3
- 230000011218 segmentation Effects 0.000 description 3
- 229920005573 silicon-containing polymer Polymers 0.000 description 3
- 244000005714 skin microbiome Species 0.000 description 3
- 239000012265 solid product Substances 0.000 description 3
- 230000006641 stabilisation Effects 0.000 description 3
- 238000011105 stabilization Methods 0.000 description 3
- 210000004304 subcutaneous tissue Anatomy 0.000 description 3
- 230000000699 topical effect Effects 0.000 description 3
- CPKVUHPKYQGHMW-UHFFFAOYSA-N 1-ethenylpyrrolidin-2-one;molecular iodine Chemical compound II.C=CN1CCCC1=O CPKVUHPKYQGHMW-UHFFFAOYSA-N 0.000 description 2
- 239000002677 5-alpha reductase inhibitor Substances 0.000 description 2
- 102000007469 Actins Human genes 0.000 description 2
- 108010085238 Actins Proteins 0.000 description 2
- 208000019901 Anxiety disease Diseases 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 208000025309 Hair disease Diseases 0.000 description 2
- 239000004944 Liquid Silicone Rubber Substances 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- 206010060862 Prostate cancer Diseases 0.000 description 2
- 208000000236 Prostatic Neoplasms Diseases 0.000 description 2
- 206010040880 Skin irritation Diseases 0.000 description 2
- 208000024427 X-linked hypohidrotic ectodermal dysplasia Diseases 0.000 description 2
- 241000209149 Zea Species 0.000 description 2
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 2
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 2
- 206010000269 abscess Diseases 0.000 description 2
- 210000002867 adherens junction Anatomy 0.000 description 2
- 208000004631 alopecia areata Diseases 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 230000036506 anxiety Effects 0.000 description 2
- 230000003416 augmentation Effects 0.000 description 2
- 230000036621 balding Effects 0.000 description 2
- 229940064804 betadine Drugs 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 239000007767 bonding agent Substances 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 238000012512 characterization method Methods 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 230000003749 cleanliness Effects 0.000 description 2
- 229920001577 copolymer Polymers 0.000 description 2
- 235000005822 corn Nutrition 0.000 description 2
- 230000034994 death Effects 0.000 description 2
- 210000004207 dermis Anatomy 0.000 description 2
- 208000034653 disorder of pilosebaceous unit Diseases 0.000 description 2
- 230000005059 dormancy Effects 0.000 description 2
- 229960004199 dutasteride Drugs 0.000 description 2
- JWJOTENAMICLJG-QWBYCMEYSA-N dutasteride Chemical compound O=C([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)N[C@@H]4CC3)C)CC[C@@]21C)NC1=CC(C(F)(F)F)=CC=C1C(F)(F)F JWJOTENAMICLJG-QWBYCMEYSA-N 0.000 description 2
- 206010016165 failure to thrive Diseases 0.000 description 2
- 230000003645 female-pattern hair loss Effects 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 230000003661 hair follicle regeneration Effects 0.000 description 2
- 230000009579 hair morphogenesis Effects 0.000 description 2
- 230000003741 hair volume Effects 0.000 description 2
- 230000003284 homeostatic effect Effects 0.000 description 2
- 239000000017 hydrogel Substances 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 230000000670 limiting effect Effects 0.000 description 2
- 238000013160 medical therapy Methods 0.000 description 2
- 238000002483 medication Methods 0.000 description 2
- 150000002739 metals Chemical class 0.000 description 2
- 230000003278 mimic effect Effects 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 230000017074 necrotic cell death Effects 0.000 description 2
- 230000001537 neural effect Effects 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 230000010399 physical interaction Effects 0.000 description 2
- 230000035479 physiological effects, processes and functions Effects 0.000 description 2
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 2
- 229920002239 polyacrylonitrile Polymers 0.000 description 2
- 239000004926 polymethyl methacrylate Substances 0.000 description 2
- 230000002028 premature Effects 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 230000004800 psychological effect Effects 0.000 description 2
- 230000008707 rearrangement Effects 0.000 description 2
- 238000009877 rendering Methods 0.000 description 2
- 238000007493 shaping process Methods 0.000 description 2
- 230000037380 skin damage Effects 0.000 description 2
- 206010040872 skin infection Diseases 0.000 description 2
- 230000036556 skin irritation Effects 0.000 description 2
- 231100000475 skin irritation Toxicity 0.000 description 2
- 239000000344 soap Substances 0.000 description 2
- 210000000130 stem cell Anatomy 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 229920002994 synthetic fiber Polymers 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 230000036642 wellbeing Effects 0.000 description 2
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 206010001766 Alopecia totalis Diseases 0.000 description 1
- 206010001767 Alopecia universalis Diseases 0.000 description 1
- 206010004446 Benign prostatic hyperplasia Diseases 0.000 description 1
- 102000000905 Cadherin Human genes 0.000 description 1
- 108050007957 Cadherin Proteins 0.000 description 1
- 208000000094 Chronic Pain Diseases 0.000 description 1
- 102100026735 Coagulation factor VIII Human genes 0.000 description 1
- 206010010356 Congenital anomaly Diseases 0.000 description 1
- 206010011732 Cyst Diseases 0.000 description 1
- 206010068516 Encapsulation reaction Diseases 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 101000911390 Homo sapiens Coagulation factor VIII Proteins 0.000 description 1
- WOBHKFSMXKNTIM-UHFFFAOYSA-N Hydroxyethyl methacrylate Chemical compound CC(=C)C(=O)OCCO WOBHKFSMXKNTIM-UHFFFAOYSA-N 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010020864 Hypertrichosis Diseases 0.000 description 1
- 208000026350 Inborn Genetic disease Diseases 0.000 description 1
- 208000010038 Ischemic Optic Neuropathy Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010030924 Optic ischaemic neuropathy Diseases 0.000 description 1
- 208000037581 Persistent Infection Diseases 0.000 description 1
- 208000004403 Prostatic Hyperplasia Diseases 0.000 description 1
- 208000001818 Pseudofolliculitis barbae Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 229920001247 Reticulated foam Polymers 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- 208000033809 Suppuration Diseases 0.000 description 1
- 208000024799 Thyroid disease Diseases 0.000 description 1
- 102000000591 Tight Junction Proteins Human genes 0.000 description 1
- 108010002321 Tight Junction Proteins Proteins 0.000 description 1
- 208000002474 Tinea Diseases 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- 241000893966 Trichophyton verrucosum Species 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- 208000038016 acute inflammation Diseases 0.000 description 1
- 230000006022 acute inflammation Effects 0.000 description 1
- 210000000577 adipose tissue Anatomy 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 208000032775 alopecia universalis congenita Diseases 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 238000003491 array Methods 0.000 description 1
- 230000003190 augmentative effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000021164 cell adhesion Effects 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 238000002659 cell therapy Methods 0.000 description 1
- 230000036755 cellular response Effects 0.000 description 1
- 230000005754 cellular signaling Effects 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 238000012993 chemical processing Methods 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- NEHMKBQYUWJMIP-UHFFFAOYSA-N chloromethane Chemical compound ClC NEHMKBQYUWJMIP-UHFFFAOYSA-N 0.000 description 1
- 230000012085 chronic inflammatory response Effects 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 229940121657 clinical drug Drugs 0.000 description 1
- 210000001072 colon Anatomy 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 238000011960 computer-aided design Methods 0.000 description 1
- 238000010226 confocal imaging Methods 0.000 description 1
- 230000001595 contractor effect Effects 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 230000007797 corrosion Effects 0.000 description 1
- 238000005260 corrosion Methods 0.000 description 1
- 239000003246 corticosteroid Substances 0.000 description 1
- 229960001334 corticosteroids Drugs 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 239000003431 cross linking reagent Substances 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 208000031513 cyst Diseases 0.000 description 1
- 230000037416 cystogenesis Effects 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 230000035617 depilation Effects 0.000 description 1
- 210000001047 desmosome Anatomy 0.000 description 1
- 230000001687 destabilization Effects 0.000 description 1
- 230000001066 destructive effect Effects 0.000 description 1
- 230000001627 detrimental effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000011038 discontinuous diafiltration by volume reduction Methods 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- 238000007876 drug discovery Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 210000004728 ear cartilage Anatomy 0.000 description 1
- 230000008451 emotion Effects 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000000720 eyelash Anatomy 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 208000016361 genetic disease Diseases 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000007952 growth promoter Substances 0.000 description 1
- 230000037308 hair color Effects 0.000 description 1
- 230000003781 hair follicle cycle Effects 0.000 description 1
- 230000003659 hair regrowth Effects 0.000 description 1
- 210000004919 hair shaft Anatomy 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000002962 histologic effect Effects 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 108091008039 hormone receptors Proteins 0.000 description 1
- 230000035874 hyperreactivity Effects 0.000 description 1
- 230000008105 immune reaction Effects 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 230000000899 immune system response Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 230000004968 inflammatory condition Effects 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 238000012977 invasive surgical procedure Methods 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 238000005468 ion implantation Methods 0.000 description 1
- 235000000396 iron Nutrition 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 230000036445 liquid secretion Effects 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 230000001926 lymphatic effect Effects 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 230000036244 malformation Effects 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 229910052752 metalloid Inorganic materials 0.000 description 1
- 150000002738 metalloids Chemical class 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 239000002114 nanocomposite Substances 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 201000002761 non-arteritic anterior ischemic optic neuropathy Diseases 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 230000037368 penetrate the skin Effects 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 230000008447 perception Effects 0.000 description 1
- 238000011422 pharmacological therapy Methods 0.000 description 1
- 230000037081 physical activity Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 1
- 239000004810 polytetrafluoroethylene Substances 0.000 description 1
- 235000017924 poor diet Nutrition 0.000 description 1
- 239000010970 precious metal Substances 0.000 description 1
- 238000002203 pretreatment Methods 0.000 description 1
- 238000007639 printing Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 210000002307 prostate Anatomy 0.000 description 1
- 230000009993 protective function Effects 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 230000036647 reaction Effects 0.000 description 1
- 238000002278 reconstructive surgery Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 238000004626 scanning electron microscopy Methods 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 229910000077 silane Inorganic materials 0.000 description 1
- 150000004760 silicates Chemical class 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 230000036559 skin health Effects 0.000 description 1
- 210000003625 skull Anatomy 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000004381 surface treatment Methods 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 210000000106 sweat gland Anatomy 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 239000012209 synthetic fiber Substances 0.000 description 1
- 229920001059 synthetic polymer Polymers 0.000 description 1
- 230000007474 system interaction Effects 0.000 description 1
- 210000005196 temporal scalp Anatomy 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 208000021510 thyroid gland disease Diseases 0.000 description 1
- 230000008467 tissue growth Effects 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- 229940100611 topical cream Drugs 0.000 description 1
- 229940126702 topical medication Drugs 0.000 description 1
- 230000003762 total hair loss Effects 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 230000005641 tunneling Effects 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/10—Hair or skin implants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2220/00—Fixations or connections for prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2220/0008—Fixation appliances for connecting prostheses to the body
- A61F2220/0016—Fixation appliances for connecting prostheses to the body with sharp anchoring protrusions, e.g. barbs, pins, spikes
Landscapes
- Health & Medical Sciences (AREA)
- Transplantation (AREA)
- Vascular Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Dermatology (AREA)
- Cardiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Prostheses (AREA)
- Materials For Medical Uses (AREA)
Abstract
L'invention porte sur un implant capillaire ayant un ancrage comprenant un corps d'ancrage, et au moins une structure de réception de collagène choisie dans le groupe constitué par au moins un tunnel à travers le corps d'ancrage ou un élément de surface externe de corps d'ancrage. L'ancrage comprend au moins un brin de cheveux faisant saillie à partir d'une extrémité distale du corps d'ancrage et peut comprendre un coude, la ou les structures de réception de collagène, ou l'élément de surface externe, supportant la croissance de ligature de collagène après implantation d'implant capillaire pour un ancrage dans le receveur. L'implant capillaire comprend une construction en deux parties ayant un module de base formé du corps d'ancrage et au moins une tige de cheveux pour le couplage avec un brin de cheveux longs. Une autre variante comprend une première extrémité de brin de cheveux qui est passée à travers la peau, sous et en remontant ensuite à travers la peau à un autre emplacement pour conduire à ce que la mèche de cheveux ait deux parties faisant saillie à partir de la surface de peau.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US17/523,472 US20220061982A1 (en) | 2017-07-31 | 2021-11-10 | Hair implants comprising enhanced anchoring and medical safety features |
US17/523,472 | 2021-11-10 | ||
PCT/US2022/049490 WO2023086439A1 (fr) | 2021-11-10 | 2022-11-10 | Implants capillaires comprenant des caractéristiques d'ancrage et de sécurité médicale améliorées |
Publications (1)
Publication Number | Publication Date |
---|---|
CA3237383A1 true CA3237383A1 (fr) | 2023-05-19 |
Family
ID=86336715
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA3237383A Pending CA3237383A1 (fr) | 2021-11-10 | 2022-11-10 | Implants capillaires comprenant des caracteristiques d'ancrage et de securite medicale ameliorees |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU2022388622A1 (fr) |
CA (1) | CA3237383A1 (fr) |
WO (1) | WO2023086439A1 (fr) |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030195625A1 (en) * | 2002-04-15 | 2003-10-16 | Garcia Castro Marco A. | Biodegradable follicle hair implant |
US6938624B2 (en) * | 2003-01-30 | 2005-09-06 | Hairlocs, Inc. | Methods and devices for applying hair extensions |
US20070067033A1 (en) * | 2005-09-16 | 2007-03-22 | Bonati Alfred O | Hair replacement method |
CN102665579B (zh) * | 2009-11-27 | 2015-07-08 | 海尔斯特提斯有限公司 | 毛发植入锚和系统及其使用方法 |
US10561490B2 (en) * | 2017-07-31 | 2020-02-18 | Loria Products Llc | Hair implants comprising enhanced anchoring and medical safety features |
-
2022
- 2022-11-10 WO PCT/US2022/049490 patent/WO2023086439A1/fr active Application Filing
- 2022-11-10 CA CA3237383A patent/CA3237383A1/fr active Pending
- 2022-11-10 AU AU2022388622A patent/AU2022388622A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
AU2022388622A1 (en) | 2024-06-20 |
WO2023086439A1 (fr) | 2023-05-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11452592B2 (en) | Hair implants comprising enhanced anchoring and medical safety features | |
US10105212B1 (en) | Hair implants comprising enhanced anchoring and medical safety features | |
US10561490B2 (en) | Hair implants comprising enhanced anchoring and medical safety features | |
JP2020529909A5 (fr) | ||
CN104661695B (zh) | 用于皮肤改善的递送装置和方法 | |
CA3132631A1 (fr) | Implants capillaires comprenant des caracteristiques d'ancrage et de securite medicale ameliorees | |
US11564789B2 (en) | Hair implants comprising enhanced anchoring and medical safety features | |
US20220061982A1 (en) | Hair implants comprising enhanced anchoring and medical safety features | |
US20230157809A1 (en) | Hair implants comprising enhanced anchoring and medical safety features | |
US20220226101A1 (en) | Hair implants comprising enhanced anchoring and medical safety features | |
CA3237383A1 (fr) | Implants capillaires comprenant des caracteristiques d'ancrage et de securite medicale ameliorees | |
RU2812035C2 (ru) | Волосяные импланты, обеспечивающие улучшенное крепление и усиленные меры медицинской безопасности | |
RU2776439C2 (ru) | Волосяные имплантаты с усиленной фиксацией и характеристиками медицинской безопасности | |
RU2776439C9 (ru) | Волосяные имплантаты с усиленной фиксацией и характеристиками медицинской безопасности |